Evidence map›Paper›PMID 40788534›Full record

ArticlePhysical and engineering sciences in medicine2025

Explainable hierarchical machine-learning approaches for multimodal prediction of conversion from mild cognitive impairment to Alzheimer's disease.

Soheil Zarei, Mohsen Saffar, Reza Shalbaf, Peyman Hassani Abharian, Ahmad Shalbaf

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soheil ZareiInstitute for Cognitive Science Studies, Tehran, Iran.ORCID http://orcid.org/0009-0005-5511-1888
Mohsen SaffarDepartment of Electrical Engineering, Iran University of Science and Technology, Tehran, Iran.
Reza ShalbafInstitute for Cognitive Science Studies, Tehran, Iran.ORCID http://orcid.org/0000-0002-1657-3802
Peyman Hassani AbharianInstitute for Cognitive Science Studies, Tehran, Iran.ORCID http://orcid.org/0000-0003-4683-066X
Ahmad ShalbafDepartment of Biomedical Engineering and Medical Physics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. shalbaf@sbmu.ac.ir.ORCID http://orcid.org/0000-0002-1595-7281

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that challenges early diagnosis and intervention, yet the black-box nature of many predictive models limits clinical adoption. In this study, we developed an advanced machine learning (ML) framework that integrates hierarchical feature selection with multiple classifiers to predict progression from mild cognitive impairment (MCI) to AD. Using baseline data from 580 participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI), categorized into stable MCI (sMCI) and progressive MCI (pMCI) subgroups, we analyzed features both individually and across seven key groups. The neuropsychological test group exhibited the highest predictive power, with several of the top individual predictors drawn from this domain. Hierarchical feature selection combining initial statistical filtering and machine learning based refinement, narrowed the feature set to the eight most informative variables. To demystify model decisions, we applied SHAP-based (SHapley Additive exPlanations) explainability analysis, quantifying each feature's contribution to conversion risk. The explainable random forest classifier, optimized on these selected features, achieved 83.79% accuracy (84.93% sensitivity, 83.32% specificity), outperforming other methods and revealing hippocampal volume, delayed memory recall (LDELTOTAL), and Functional Activities Questionnaire (FAQ) scores as the top drivers of conversion. These results underscore the effectiveness of combining diverse data sources with advanced ML models, and demonstrate that transparent, SHAP-driven insights align with known AD biomarkers, transforming our model from a predictive black box into a clinically actionable tool for early diagnosis and patient stratification.

Indexed as

Alzheimer DiseaseCognitive DysfunctionMachine LearningAgedAged, 80 and overDisease ProgressionFemaleHumansMaleNeuropsychological TestsAlzheimer’s diseaseExplainable AIFeature selectionMachine learningMild cognitive impairmentPredictive modeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.